New COPD inhaler shows promise in early trial
NCT ID NCT07331402
First seen Jan 10, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study tests an experimental inhaled drug called HSK39004 in 12 adults with COPD. The goal is to measure how the drug moves through the body and how it affects lung function over 12 hours. Participants receive the drug and a control treatment in a crossover design to compare results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD PATIENTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
36 Sanhao Street, Heping District, Shenyang, Liaoning,China
Shenyang, Liaoning, China
Conditions
Explore the condition pages connected to this study.